SITE SEARCH | NEWS | EARNINGS | CALENDARS | MUTUAL FUNDS
Sector Tables: Energy - Retail - Utilities - REIT - Banks - Brokerage - ETFs | Oil Data
Login | Subscribe to Ticker
Market Update Analysis: 
GameStop, Nuvelo and Aruba Up
Author: 123jump.com Staff
123jump.com
Last Update: 3:15 PM EDT March 27 2007


Market averages traded near the lowest level in the last hour of trading. Weak consumer confidence and a decline in housing index dragged broader averages lower. Housing stocks corrected on lower than expected earnings at Lennar. GameStop reported earnings of 81 cents up from 55 cnets a year ago. Aruba Networks launched its IPO at $11 per share.

 
2:30PM NY, U.S. Market Movers

In New York trading stocks traded lower on weak consumer confidence and decline in level of housing index. New issue of Aruba Networks rose 24% on its first day of trading.

Akorn (AKRX: chart) said it has signed a three-year distribution agreement with publicly-operated manufacturer Massachusetts Biologic Laboratories for tetanus diphtheria vaccine. Akorn said it expects the deal to add 10 cents to 11 cents a share per year to its earnings, with revenue in excess of $150 million over the course of the agreement which begins on Sept. 1, 2007. Shares climbed 10.6%.

FuelCell Energy (FCEL: chart) shares surged 21.8% after the company announced a lucrative deal to supply fuel cell power products to Connecticut. The Connecticut Clean Energy Fund selected FuelCell for six power projects that would total about 68 megawatts, the company said Tuesday. The deal would be valued at $200 million if all the projects are approved.

GameStop Corp. (GME: chart) shares jumped 11% after the video-game retailer''s fourth-quarter results and current-year guidance topped forecasts. For the quarter the company earned $129.8 million, or 81 cents a share, on revenue of $2.3 billion. During the year-earlier period, the company earned $85 million, or 55 cents a share, on revenue of $1.67 billion.

Nuvelo Inc. (NUVO: chart) jumped 24.6% after the Food and Drug Administration gave the company two fast-track designations for its colorectal cancer drug, rNAPc2. The move enables Nuvelo to submit information for its market application on a rolling basis.

BioCryst Pharmaceuticals (BCRX: chart) said it has placed a hold on a Phase II clinical trial for its intravenous leukemia treatment Fodosine due to problems with the drug''s stability. The company slumped 17.4%.

Electronic Clearing House (ECHO: chart) said that it was a witness in a federal investigation and would no longer be acquired by financial software maker Intuit Inc., pushing its shares down 35.4%.

Hawaiian Holdings Inc. (HA: chart) shares slumped 23.1% after the parent of Hawaiian Airlines said a bitter fare war will cut into its first-quarter results. Hawaiian said it expects first-quarter passenger yield to fall 11% to 12% from the first quarter of 2006.

LL&E Royalty Trust (LRT: chart) announced there will be no Trust income distribution for the month of April 2007 for Unit holders of record on April 5, 2007. This release relates to production for the month of January 2007. Trust related expenses for the month of January 2007 totaled $105,051 while Royalty income for the month of January 2007 will be $91,359. Trust expenditures in excess of royalty income received will reduce the Trust''s reserve for Trust expenses.

Metropolitan Health Networks Inc. (MDF: chart) shares fell 9.7% after the healthcare services provider posted a fourth-quarter net loss of $2.72 million, or 5 cents per share, compared with a net loss of $545,138, or a penny per share, in the year-ago period. Revenue jumped 18.4%, to $55.7 million versus $47.1 million in the same period last year.

Cimatron Ltd. (CIMT: chart) shares more than doubled in value after the company swung to a fourth-quarter profit of $557,000, or 7 cents per share, on revenue that climbed 11% from last year to $6 million.

Aruba Networks (ARUN: chart) maker of wireless networking products jumped 24.1% on their first day of trading. The company''s initial public offering of 8 million shares priced at $11 a piece, above the projected range of $8 to $10.

Barrier Therapeutics Inc. (BTRX: chart) said a mid-stage trial of its oral antifungal product candidate, pramiconazole, met both the main and secondary goals. The main goal of the study was to treat tinea versicolor, a common skin fungal infection characterized by a discolored, scaly, itchy rash primarily on the back, chest and upper arms. Shares of the company jumped 8.4%.

1:30PM NY – 5:30PM Frankfurt – European Markets Close

European markets across the region rose in the morning trading but closed lower as the market neared the close. Germany closed higher led by a rise in auto stocks. DaimlerChrysler (DCX: chart) rose 3% on the market belief that the sale of its Chrysler Group is imminent. BNP Paribas rose target for the DaimlerChrysler to 70 euros from 62 euros. Morgan Stanley raised its target price to 75 euros from 62 euros.

Porsche rose 2.8% to 1,153 euros on the news that the company has raised its stake to 30.9% in Volkswagen triggering a takeover bid threshold. However, the company said that it is not likely to pay more than 101 euros for additional stake of Volkswagen. VW stock fell 3% to 110.50 euros.

German athletic footwear maker Adidas jumped 5% to 41.15 euros on takeover rumors and broker upgrade.

Siemens board member, Johannes Feldmayer, was arrested today in connection with investigation related to an illegal financing of a trade union rival to its main union. The company is under investigation for its activities related to breach of trust for the last two years.

Mining and energy stocks led main index in London slightly higher in a quite trading. Rio Tinto (RTP: chart), Mittal (MT: chart) and BHP Billiton (BHP: chart) closed higher. Belgium closed 0.53% up and Spain rose 0.4% at close however, Norway fell 0.6% and Switzerland dropped 0.44%.
  1  2  3

 

 
About Us | Contact Us | Privacy Policy | Disclaimer

©1999-2008 123jump.com. All rights reserved